Lin Elizabeth Yeu

Insider CIK 1842190 · TARS Chief Medical Officer, Director · STAA Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-04	2026-09-09	5,386	$90.00	$484.7K	2,547	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-04	2026-09-09	5,387	$85.00	$457.9K	7,933	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-04	2026-09-09	1,590	$90.00	$143.1K	1,590	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-04	2026-09-09	1,590	$85.00	$135.2K	3,180	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-04	2026-09-09	1,590	$90.00	$143.1K	1,590	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-04	2026-09-09	1,590	$85.00	$135.2K	3,180	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-04	2026-09-09	5,386	$90.00	$484.7K	2,547	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-04	2026-09-09	5,387	$85.00	$457.9K	7,933	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-02	2026-09-03	5,387	$80.00	$431.0K	13,320	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-02	2026-09-03	1,590	$80.00	$127.2K	4,770	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-02	2026-09-03	1,590	$80.00	$127.2K	4,770	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-02	2026-09-03	5,387	$80.00	$431.0K	13,320	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-01	2026-09-03	4,601	$73.86	$339.8K	18,707	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-09-01	2026-09-03	4,601	$73.86	$339.8K	18,707	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-03-19	2026-03-19	390	$67.00	$26.1K	23,308	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-03-18	2026-03-19	379	$68.71	$26.0K	23,698	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-03-17	2026-03-19	375	$69.42	$26.0K	24,077	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2026-03-15	2026-03-17	2,511	—	$0	7,534	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2026-03-15	2026-03-17	2,511	—	$0	24,452	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2026-03-05	2026-03-09	27,310	—	$0	27,310	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2026-03-05	2026-03-09	17,161	—	$0	17,161	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2025-12-16	2025-12-17	2,078	$79.50	$165.2K	21,941	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2025-12-15	2025-12-17	6,819	—	$0	20,459	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2025-12-15	2025-12-17	6,819	—	$0	24,019	SEC↗
STAA STAAR SURGICAL CO	A Award deriv	2025-06-18	2025-06-20	9,708	—	$0	9,708	SEC↗
STAA STAAR SURGICAL CO	A Award deriv	2025-06-18	2025-06-20	5,341	—	$0	5,341	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2025-06-16	2025-06-17	1,006	$41.08	$41.3K	7,694	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2025-06-13	2025-06-17	3,350	—	$0	0	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2025-06-13	2025-06-17	3,350	—	$0	8,700	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2025-03-05	2025-03-07	10,045	—	$0	10,045	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2025-03-05	2025-03-07	15,314	—	$0	15,314	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2024-11-04	2024-11-06	41,074	—	$0	41,074	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2024-11-04	2024-11-06	27,278	—	$0	27,278	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2024-06-24	2024-06-25	3,350	—	$0	0	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2024-06-24	2024-06-25	3,350	—	$0	5,350	SEC↗
STAA STAAR SURGICAL CO	A Award deriv	2024-06-20	2024-06-24	4,010	—	$0	4,010	SEC↗
STAA STAAR SURGICAL CO	A Award	2024-06-20	2024-06-24	2,244	—	$0	5,099	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2024-06-13	2024-06-14	3,350	—	$0	3,350	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2024-06-13	2024-06-14	5,000	—	$0	5,000	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2024-01-25	2024-01-30	10,000	—	$0	10,000	SEC↗
STAA STAAR SURGICAL CO	P Buy	2023-09-21	2023-09-22	2,500	$40.00	$100.0K	2,855	SEC↗
TARS Tarsus Pharmaceuticals, In	P Buy	2023-08-15	2023-08-17	9,506	$16.80	$159.7K	15,866	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2023-06-22	2023-06-26	3,350	—	$0	3,350	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2023-06-22	2023-06-26	5,000	—	$0	5,000	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2023-06-16	2023-06-21	2,000	—	$0	0	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2023-06-16	2023-06-21	2,000	—	$0	2,000	SEC↗
STAA STAAR SURGICAL CO	M Exercise deriv	2023-06-15	2023-06-16	6,256	—	$0	6,256	SEC↗
TARS Tarsus Pharmaceuticals, In	P Buy	2022-09-14	2022-09-16	6,360	$16.29	$103.6K	6,360	SEC↗
TARS Tarsus Pharmaceuticals, In	P Buy	2022-09-14	2022-09-16	12,040	$16.03	$193.0K	12,040	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2022-06-16	2022-07-01	2,000	—	$0	2,000	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2022-06-16	2022-07-01	7,000	—	$0	7,000	SEC↗
STAA STAAR SURGICAL CO	M Exercise deriv	2022-06-16	2022-06-17	5,765	—	$0	5,765	SEC↗
STAA STAAR SURGICAL CO	M Exercise	2022-06-16	2022-06-17	355	—	$0	355	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2021-12-31	2022-01-04	20,000	—	$0	20,000	SEC↗
STAA STAAR SURGICAL CO	A Award deriv	2021-06-24	2021-06-25	1,703	—	$0	1,703	SEC↗
STAA STAAR SURGICAL CO	A Award deriv	2021-01-21	2021-01-26	1,367	—	$0	1,367	SEC↗